CAVACURMIN®, developed by WACKER, is an innovative curcumin complex that addresses the common challenge of curcumin’s poor absorption due to its fat solubility. By utilizing gamma-cyclodextrin (CAVAMAX® W8), a naturally occurring oligosaccharide, to form a complex with curcumin, CAVACURMIN® significantly enhances its absorption and bioavailability. Specifically, it achieves a 40-fold increase in absorption and an 18-fold higher bioavailability compared to standard turmeric extract.
CAVACURMIN® represents a significant advancement in curcumin supplementation, providing a more effective, efficient, and versatile option for those seeking the health benefits of curcumin.
In Vivo Bioavailability in a Rodent Model (2009): Animals (rats) that received CAVACURMIN® had 8 to 20 times more total curcuminoids in their blood plasma (expressed as the sum of free curcumin and its metabolites) than animals that received a commercial product or pure curcumin powder.
In Vitro Bioavailability in a Human Caco-2 Model (2011): CAVACURMIN® dissolved up to five times more efficiently than leading commercial curcumin supplement products or curcumin powder itself.
Human Bioavailability in a Clinical Study (2013): CAVACURMIN® was about 40 times more efficiently absorbed than leading commercial curcumin supplement products or curcumin powder itself.
In Vivo Bioavailability in a Rodent Model (2009): Animals (rats) that received CAVACURMIN® had 8 to 20 times more total curcuminoids in their blood plasma (expressed as the sum of free curcumin and its metabolites) than animals that received a commercial product or pure curcumin powder.
In Vitro Bioavailability in a Human Caco-2 Model (2011): CAVACURMIN® dissolved up to five times more efficiently than leading commercial curcumin supplement products or curcumin powder itself.
Human Bioavailability in a Clinical Study (2013): CAVACURMIN® was about 40 times more efficiently absorbed than leading commercial curcumin supplement products or curcumin powder itself.
Contact us:
Sitemap:
